SCHEMBL4400749

SCHEMBL4400749

CC(C)COc1cccc2[nH]c(OC(=O)Nc3ccc([C@@H](C)N(C)C4CCOCC4)cc3)cc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER1 P34995 1/20 0.34
CYP2D6 P10635 2/20 0.34
ALDH1A1 P00352 2/20 0.34
HSD17B10 Q99714 2/20 0.34
KDM4E B2RXH2 1/20 0.34
CYP1A2 P05177 1/20 0.34
ADRB3 P13945 4/20 0.34
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
LMNA P02545 2/20 0.34
MAPT P10636 2/20 0.34
HTR1A P08908 2/20 0.34
SLC6A2 P23975 2/20 0.34
MLNR O43193 1/20 0.34
NR1I2 O75469 1/20 0.34
ADRB2 P07550 1/20 0.34
ADRB1 P08588 1/20 0.34
DRD2 P14416 1/20 0.34
ADRA2C P18825 1/20 0.34
HTR2A P28223 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4405573 0.88 CCR5 (0.42) PTGER1CYP2D6ALDH1A1HSD17B10KDM4E
SCHEMBL914632 0.87 KMT2A (0.47) CYP2D6ALDH1A1HSD17B10KDM4ECYP1A2
SCHEMBL4411253 0.78 LMNA (0.35) PTGER1CYP2D6ALDH1A1HSD17B10KDM4E
SCHEMBL914650 0.75 MEN1 (0.47) CYP2D6ALDH1A1HSD17B10KDM4ECYP1A2
SCHEMBL12975788 0.75 ALOX15 (0.34) PTGER1ALDH1A1HSD17B10KDM4EMEN1
SCHEMBL4409139 0.73 ADRB3 (0.41) PTGER1ADRB3MEN1KMT2A
SCHEMBL6963102 0.68 KDM4E (0.38) CYP2D6ALDH1A1HSD17B10KDM4ECYP1A2
SCHEMBL914267 0.68 KDM4E (0.38) CYP2D6ALDH1A1HSD17B10KDM4ECYP1A2
SCHEMBL4551166 0.67 LMNA (0.42) ALDH1A1ADRB3LMNAMAPTHTR1A
SCHEMBL4405571 0.67 KDM4E (0.39) ALDH1A1HSD17B10KDM4EADRB3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1720859-B1 CHEMOKINE RECEPTOR ANTAGONISTS NOVARTIS AG (CH) 2009-12-23 EP claimed